KisoJi Biotechnology

www.kisojibiotech.com
3576 avenue du Parc, Suite 4310
Montreal, QC H2X 2J1

Company Info

Year Established
2009

Contacts

Gordon Ngan
VP, Business Development

Michael Dixon, CPA, CA
CFO

David S. Young, M.D.
Co-Founder & CEO

Luis da Cruz, Ph.D.
VP, Research

Company Description

KisoJi, an adMare company, is a privately-held next-generation antibody company developing multi-specific antibodies to improve outcomes in oncology.